Loading clinical trials...
Loading clinical trials...
Comparison of Treatment Efficacy of Automated Robotic Maneuvering System (RMS) Reposition Chair Versus Traditional Manual Repositioning Maneuvers in Benign Paroxysmal Positional Vertigo (BPPV)
Comparison of treatment efficacy of an automated robotic maneuvering system (RMS) repositioning chair versus manual positioning maneuvers in Benign Paroxysmal Positional Vertigo.
The standard treatments for Benign Paroxysmal Positional Vertigo (BPPV) are manual positioning maneuvers. This method, beyond being costly and requiring extensive training, is a significant burden on healthcare resources. We developed an automated robotic maneuvering system, hereby known as RMS, to tackle this problem. Our Clinical Investigation is two-fold; (1) test the safety of RMS and, (2) understand the viability of RMS for treating BPPV when compared to manual positioning maneuvers.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Haseki Sultangazi Training and Research Hospital
Istanbul, Sultangazi, Turkey (Türkiye)
Start Date
February 15, 2022
Primary Completion Date
April 12, 2022
Completion Date
April 23, 2022
Last Updated
April 29, 2022
75
ACTUAL participants
Automated vertigo repositioning chair
DEVICE
Canalith Reposition Maneuver
OTHER
Lead Sponsor
Stratejik Yenilikci Girisimler Ltd.
Collaborators
NCT06725966
NCT06314581
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT07111000